From April 1, 2022 to June 30, 2022, the company has repurchased 2,932,610 shares, representing 0.5% for CNY 132.62 million. With this, the company has completed the repurchase of 4,416,310 shares, representing 0.75% for CNY 205.11 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.7 CNY | -1.66% | -3.58% | +2.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.96% | 4.72B | |
-4.69% | 8.1B | |
-3.63% | 5.13B | |
-32.76% | 4.4B | |
-0.97% | 4.14B | |
+15.50% | 2.82B | |
+3.24% | 2.55B | |
+12.80% | 1.92B | |
-1.77% | 1.65B | |
-2.09% | 1.52B |
- Stock
- Equities
- Stock Autobio Diagnostics Co., Ltd. - Shanghai S.E.
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.